HER2 Positive Breast Cancer

Produk Detail:
  • Author : Sara Hurvitz
  • Publisher : Elsevier Health Sciences
  • Pages : 264 pages
  • ISBN : 0323581234
  • Rating : /5 from reviews
CLICK HERE TO GET THIS BOOK >>>HER2 Positive Breast Cancer

Download or Read online HER2 Positive Breast Cancer full in PDF, ePub and kindle. this book written by Sara Hurvitz and published by Elsevier Health Sciences which was released on 26 July 2018 with total page 264 pages. We cannot guarantee that HER2 Positive Breast Cancer book is available in the library, click Get Book button and read full online book in your kindle, tablet, IPAD, PC or mobile whenever and wherever You Like. Get a quick, expert overview of clinically-focused topics and guidelines that are relevant to testing for HER2, which contributes to approximately 25% of breast cancers today. This concise resource by Drs. Sara Hurvitz, and Kelly McCann consolidates today’s available information on this growing topic into one convenient resource, making it an ideal, easy-to-digest reference for practicing and trainee oncologists.

HER2 Positive Breast Cancer

HER2 Positive Breast Cancer
  • Author : Sara Hurvitz,Kelly McCann
  • Publisher : Elsevier Health Sciences
  • Release : 26 July 2018
GET THIS BOOK HER2 Positive Breast Cancer

Get a quick, expert overview of clinically-focused topics and guidelines that are relevant to testing for HER2, which contributes to approximately 25% of breast cancers today. This concise resource by Drs. Sara Hurvitz, and Kelly McCann consolidates today’s available information on this growing topic into one convenient resource, making it an ideal, easy-to-digest reference for practicing and trainee oncologists.

Handbook of HER2 Targeted Agents in Breast Cancer

Handbook of HER2 Targeted Agents in Breast Cancer
  • Author : Ricardo H Alvarez,Javier Cortés,Mary Falzon,Michael Gandy,Luca Gianni,Nadia Harbeck,Martine Piccart
  • Publisher : Springer
  • Release : 14 May 2016
GET THIS BOOK Handbook of HER2 Targeted Agents in Breast Cancer

This concise handbook provides oncologists and other healthcare providers with crucial updates in the field, including an updated review of the current understanding of the biology of the HER2 pathway, an overview of HER2-testing, and evidence-based discussions of available and emerging HER2-targeted treatment options. An essential clinical text for physicians that screen and treat patients with breast cancer and require an accessible, up-to-date survey of the dynamic treatment landscape.

Targeting Telomerase in HER2 Positive Breast Cancer

Targeting Telomerase in HER2 Positive Breast Cancer
  • Author : Jillian Elizabeth Koziel
  • Publisher : Unknown
  • Release : 30 July 2021
GET THIS BOOK Targeting Telomerase in HER2 Positive Breast Cancer

Cancer stem cells (CSCs) are proposed to play a major role in tumor progression, metastasis, and recurrence. The Human Epidermal growth factor Receptor 2 (HER2) gene is amplified and/or its protein product overexpressed in approximately 20% of breast cancers. HER2 overexpression is associated with increased CSCs, which may explain the aggressive phenotype and increased likelihood of recurrence for HER2+ breast cancers. Telomerase is reactivated in tumor cells, including CSCs, but has limited activity in normal tissues, providing support for the use

Mechanisms of Resistance to T DM1 in HER2 positive Breast Cancer

Mechanisms of Resistance to T DM1 in HER2 positive Breast Cancer
  • Author : Junjie Zhang
  • Publisher : Unknown
  • Release : 30 July 2021
GET THIS BOOK Mechanisms of Resistance to T DM1 in HER2 positive Breast Cancer

El cáncer de mama HER2-positivo representa alrededor del 15-30% del total de pacientes con cáncer de mama. Este subtipo tiene un mal pronóstico, seguido del subtipo Triple-negativo (TNBC), que lo tiene aún peor. Actualmente, varios medicamentos están aprobados para las pacientes HER2-positivo, como Trastuzumab, Lapatinib y T-DM1. Sin embargo, a menudo éstas adquieren resistencia a estas terapias en un período de 1 a 2 años. El objetivo principal de este estudio es definir

HER2 Testing to Manage Patients with Breast Cancer and Other Solid Tumors

HER2 Testing to Manage Patients with Breast Cancer and Other Solid Tumors
  • Author : U. S. Department of Health and Human Services,Agency for Healthcare Research and Quality
  • Publisher : Createspace Independent Pub
  • Release : 31 May 2013
GET THIS BOOK HER2 Testing to Manage Patients with Breast Cancer and Other Solid Tumors

The human epidermal growth factor receptor-2 (HER2) gene is amplified and the HER2 protein overexpressed in approximately 18–20 percent of breast cancer cases. Amplification or overexpression of HER2 is associated with poor prognosis. Evidence from randomized trials demonstrates that adding trastuzumab, a therapeutic monoclonal antibody that targets HER2, to adjuvant chemotherapy regimens for HER2-positive breast cancer improves survival. HER2 also is overexpressed in other epithelial malignancies such as ovarian, thyroid, lung, salivary gland/head and neck, stomach, colon, and prostate

HER2 Inhibitors Advances in Research and Application 2012 Edition

HER2 Inhibitors   Advances in Research and Application  2012 Edition
  • Author : Anonim
  • Publisher : ScholarlyEditions
  • Release : 26 December 2012
GET THIS BOOK HER2 Inhibitors Advances in Research and Application 2012 Edition

HER2 Inhibitors—Advances in Research and Application: 2012 Edition is a ScholarlyBrief™ that delivers timely, authoritative, comprehensive, and specialized information about HER2 Inhibitors in a concise format. The editors have built HER2 Inhibitors—Advances in Research and Application: 2012 Edition on the vast information databases of ScholarlyNews.™ You can expect the information about HER2 Inhibitors in this eBook to be deeper than what you can access anywhere else, as well as consistently reliable, authoritative, informed, and relevant. The content of HER2 Inhibitors—

HER2 Inhibitors Advances in Research and Application 2013 Edition

HER2 Inhibitors   Advances in Research and Application  2013 Edition
  • Author : Anonim
  • Publisher : ScholarlyEditions
  • Release : 21 June 2013
GET THIS BOOK HER2 Inhibitors Advances in Research and Application 2013 Edition

HER2 Inhibitors—Advances in Research and Application: 2013 Edition is a ScholarlyBrief™ that delivers timely, authoritative, comprehensive, and specialized information about ZZZAdditional Research in a concise format. The editors have built HER2 Inhibitors—Advances in Research and Application: 2013 Edition on the vast information databases of ScholarlyNews.™ You can expect the information about ZZZAdditional Research in this book to be deeper than what you can access anywhere else, as well as consistently reliable, authoritative, informed, and relevant. The content of HER2 Inhibitors—